Fig. 2. IL-2/rapamycin–expanded T cells express homing receptors to traffic to lymphoma sites and are resistant to SN-38 toxicity. IL-2/rapamycin–expanded.

Slides:



Advertisements
Similar presentations
Frank Kirstein, PhD, Natalie E
Advertisements

Fig. 3. Cytokines trigger proliferation and block differentiation of perivascular adipocytes. Cytokines trigger proliferation and block differentiation.
Preactivation with IL-12, IL-15, and IL-18 Induces CD25 and a Functional High-Affinity IL-2 Receptor on Human Cytokine-Induced Memory-like Natural Killer.
IL-21 inhibits T cell IL-2 production and impairs Treg homeostasis
Fig. 1. BCAS1 expression identifies newly generated oligodendrocytes.
Fig. 4. aPD-1 mAb transfer to macrophages is mediated by FcγRs.
PVSRIPO-mediated APC activation occurs in immunosuppressive conditions
MRSA virulence proteins cause LMC death and diminished CLV function
Fig. 6. Increased efficacy of immunotherapy in lymphangiogenic B16 melanomas depends on CCR7 signaling before therapy and local activation and expansion.
Fig. 8. mRIPO elicits neutrophil influx followed by DC and T cell infiltration into tumors. mRIPO elicits neutrophil influx followed by DC and T cell infiltration.
Fig. 1 DMF promotes viral infection.
Fig. 2. GPC3 expression in normal and tumor tissues.
Dual enhancement of T and NK cell function by pulsatile inhibition of SHIP1 improves antitumor immunity and survival by Matthew Gumbleton, Raki Sudan,
Expression of CD36 and psap in a TMA of human ovarian cancer patients
Fig. 2 Systemically released inflammatory factors directly affect HSC-e cell fate. Systemically released inflammatory factors directly affect HSC-e cell.
Fig. 4. Antitumor efficacy of ERY974 against various cancer types.
Type 1 immunity drives metabolic disease but protects against NAFLD
Fig. 5 Hypoxic tumors from obese mice associate with increased production of IL-6 by adipocytes and myeloid cells. Hypoxic tumors from obese mice associate.
Fig. 3 In situ vaccination with CpG and anti-OX40 is therapeutic in a spontaneous tumor model. In situ vaccination with CpG and anti-OX40 is therapeutic.
Fig. 2. Circulating VEGF in GCA patients up-regulates microvascular endothelial Jagged1. Circulating VEGF in GCA patients up-regulates microvascular endothelial.
Fig. 2. Binding of recombinant full-length Lm-411 to muscle receptors, myotubes, and self-polymerization is enhanced by mag and αLNNd. Binding of recombinant.
Fig. 5 Local gel scaffold for T cell memory response.
Fig. 1 BX795 suppresses HSV-1 infection.
Volume 29, Issue 6, Pages (December 2008)
Fig. 4 TNF-α up-regulates Fas/Fap-1 expression to promote IL-1RA–sEV release in murine MSCs. TNF-α up-regulates Fas/Fap-1 expression to promote IL-1RA–sEV.
In vivo validation of effects of combination therapies on subpopulation composition. In vivo validation of effects of combination therapies on subpopulation.
Fig. 7 DMN-Tre labeling of Mycobacterium tuberculosis is inhibited by tuberculosis drug cocktail, unlike auramine staining. DMN-Tre labeling of Mycobacterium.
Fig. 7. mRIPO therapy restricts tumor growth and produces antigen-specific antitumor immunity. mRIPO therapy restricts tumor growth and produces antigen-specific.
Fig. 3. VEGFR-3 signaling increases infiltration of naïve T cells in a CCR7-dependent manner. VEGFR-3 signaling increases infiltration of naïve T cells.
Volume 43, Issue 5, Pages (November 2015)
Fig. 4. Dabrafenib and trametinib changed the cellular components of the tumor microenvironment. Dabrafenib and trametinib changed the cellular components.
Selection of a 4-1BB-endodomain–based anti-EGFRvIII CAR construct
Fig. 3 CSF1 is expressed in human melanoma.
Fig. 5 DMN-Tre labeling is selective for live mycobacteria.
In Vivo Expansion of Regulatory T cells With IL-2/IL-2 mAb Complexes Prevents Anti- factor VIII Immune Responses in Hemophilia A Mice Treated With Factor.
Fig. 2. Cellular response to FolamiRs in vitro.
Fig. 1. Specificity of FolamiR uptake in cancer cells in culture.
Fig. 5 Extended local release of R848 increases the number of innate and adaptive antitumor immune cells and cytokines. Extended local release of R848.
CSF1 secretion by melanoma cells is induced by CTL-derived cytokines
MYC regulates the antitumor immune response through CD47 and PD-L1
Volume 32, Issue 1, Pages (January 2010)
Ag 85A–specific immune responses.
The mucosal environment regulates CD160 expression on IELs
Fig. 4 Labeling of Msmeg with DMN-Tre is fast and specific and depends on Ag85A function. Labeling of Msmeg with DMN-Tre is fast and specific and depends.
PD-1 blockade results in increased expression of the chemokine receptor CXCR3. PD-1 blockade results in increased expression of the chemokine receptor.
IL-33, IL-25, and TSLP induce a distinct phenotypic and activation profile in human type 2 innate lymphoid cells by Ana Camelo, Guglielmo Rosignoli, Yoichiro.
Senescence-associated defective HLA-DR upregulation does not modulate immunosuppressive properties of MSCs. (A) Fit and senescent MSCs were subjected to.
Fig. 3. Increased expression of exhaustion markers and apoptosis markers on CAR8 cells in the presence of TCR antigen. Increased expression of exhaustion.
CD25 surface expression and TCR signal strength predict T helper differentiation and memory potential of early effector T cells in vivo. CD25 surface expression.
Fig. 3 BMS blocks functional responses in primary immune cells driven by IL-23 and IL-12. BMS blocks functional responses in primary immune.
BMS blocks functional responses in primary immune cells driven by IFNα
Fig. 4 Reconstitution of MCs in KitW-sh/W-sh mice increases IL-10+ Breg cells and suppresses the CHS response. Reconstitution of MCs in KitW-sh/W-sh mice.
Vaginal CD11c+ DCs from IL-17A−/− mice are impaired in potentiating Th17 responses because of diminished IL-1β production. Vaginal CD11c+ DCs from IL-17A−/−
Possible mechanisms of recognition of MHCIlow tumor cells by NSCs
Fig. 2 Phenotypic analyses of Bcl11b-deficient Treg cells.
CD25 expression predicts effector and memory differentiation.
GPR55 regulates γδT cell egress from PP and homing of gut-tropic CD8 T cells to the small intestine. GPR55 regulates γδT cell egress from PP and homing.
ALT-803 stimulates proliferation and activation of human NK cells and T cells in vitro. ALT-803 stimulates proliferation and activation of human NK cells.
by Geoffrey A. Smith, Jack Taunton, and Arthur Weiss
Tumor-resident CD8+ T cells rapidly expand after IL-15/IL-15Rα complex treatment. Tumor-resident CD8+ T cells rapidly expand after IL-15/IL-15Rα complex.
Hypoxic Ag-specific CD8+ T cells are less functional and less proliferative. Hypoxic Ag-specific CD8+ T cells are less functional and less proliferative.
Trametinib and combination promote moDC maturation and decrease moDC viability. Trametinib and combination promote moDC maturation and decrease moDC viability.
Moderate-affinity vaccine antigens elicited greatest antitumor response. Moderate-affinity vaccine antigens elicited greatest antitumor response. Wild-type.
The effect of βAR signaling on the generation of a cytotoxic CD8+ T-cell response in vivo. The effect of βAR signaling on the generation of a cytotoxic.
Fig. 5 IL-5–mediated signaling is critical for the development of CD1dintCD5+ Breg precursor cells and IL-10+ Breg cells. IL-5–mediated signaling is critical.
IL2Cx alone or in combination with anti–CTLA-4 increases the CD8/Treg ratio in the tumor. IL2Cx alone or in combination with anti–CTLA-4 increases the.
EC-derived SP cells are targeted by CD30.CAR T cells.
Meningeal γδ T cells are biased toward IL-17 production.
Fig. 2. Cellular response to FolamiRs in vitro.
Surface expression of chemokine receptors on M
Presentation transcript:

Fig. 2. IL-2/rapamycin–expanded T cells express homing receptors to traffic to lymphoma sites and are resistant to SN-38 toxicity. IL-2/rapamycin–expanded T cells express homing receptors to traffic to lymphoma sites and are resistant to SN-38 toxicity. (A) Schematic of T cell functionalization and cell-mediated delivery of SN-38 NCs into tumors. (B and C) Polyclonal T cells from C57BL/6J mice were primed with concanavalin A and IL-7 for 2 days, then expanded in IL-2 with or without rapamycin for 2 days, and analyzed for expression of tissue-homing receptors by flow cytometry. Shown are representative staining histograms (B) and quantification markers (C) of n = 7 replicate cultures from two independent experiments. Data are means ± SEM. P value was determined by t test. MFI, median fluorescence intensity. (D) Eμ-myc cells or IL-2/rapamycin–expanded T cells were cultured in vitro with SN-38 at indicated doses, and viability was assessed by flow cytometry after 24 hours. Data are means ± SEM of pooled four to eight replicate cultures from four independent experiments. (E) IL-2– or IL-2/rapamycin–cultured T cells were taken directly from culture or incubated with SN-38 (20 ng/ml) for 12 hours, then stained for intracellular Bcl-2 expression, and analyzed by flow cytometry. Data are representative plots for n = 3 cultures per condition from one of three independent experiments. P values were determined by two-way analysis of variance (ANOVA) with Bonferroni post-test. (F) IL-2– or IL-2/rapamycin–cultured Thy1.1+ T cells (40 × 106) were adoptively transferred into C57BL/6J mice (n = 6 to 7 per group). The number of Thy1.1+ T cells in blood, spleen, and lymph nodes was enumerated by flow cytometry 2 days after transfer. Data are means ± SEM from one of two independent experiments. P values were determined by t test. Bonnie Huang et al., Sci Transl Med 2015;7:291ra94 Published by AAAS